RxDoctor Payments DataLook up a doctor →

Marcella Rowley

Primary Care · Riverton, UTNPI 1740301837

Payments from drug & device makers

$13,498in general payments, 2019–2025

Across 718 payments — averaging $18.80 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$2K
  • AstraZeneca$2K
  • Otsuka America Pharmaceutical, Inc.$1K
  • Jazz Pharmaceuticals Inc.$1K
  • Amgen$869
  • Axsome Therapeutics, Inc.$704
  • plus $6K from 54 others

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie129$1,834
AstraZeneca55$1,515
Otsuka America Pharmaceutical, Inc.59$1,037
Jazz Pharmaceuticals Inc.29$1,031
Amgen44$869
Axsome Therapeutics, Inc.31$704
Novo Nordisk68$634
Lilly USA, LLC37$564
Avadel CNS Pharmaceuticals, LLC11$427
Corcept Therapeutics16$415
Merck17$400
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)15$317
Nestle Healthcare Nutrition Inc.21$304
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC15$275
Abbott13$256
Aimmune Therapeutics, Inc.11$250
Harmony Biosciences LLC12$245
Optinose US, Inc.11$235
Evofem Biosciences, Inc.13$206
Pfizer10$148
Boehringer Ingelheim8$148
Vanda Pharmaceuticals Inc.3$97
Exact Sciences6$96
Alkermes, Inc.6$94
Supernus Pharmaceuticals, Inc.5$92
Idorsia Pharmaceuticals US Inc5$85
Takeda Pharmaceuticals U.S.A., Inc.4$71
Corium, LLC5$70
Xeris Pharmaceuticals, Inc.3$63
Collegium Pharmaceutical, Inc.3$63
IBSA Pharma Inc.3$62
Currax Pharmaceuticals LLC4$62
Ascend Therapeutics US, LLC3$61
Almatica Pharma LLC3$52
Lundbeck LLC2$44
Sanofi-aventis U.S. LLC2$41
Biohaven Pharmaceuticals, Inc.3$41
Johnson & Johnson3$39
Shield Therapeutics Inc2$37
Halozyme Inc2$37
Acella Pharmaceuticals, LLC2$34
Antares Pharma, Inc.2$32
QOL Medical, LLC1$32
Clarus Therapeutics Inc.2$32
Phathom Pharmaceuticals, Inc.2$31
Bayer1$26
Bausch Health US, LLC2$26
Vertex1$26
C. R. Bard, Inc. & Subsidiaries1$24
Scynexis, Inc.1$22
Redhill Biopharma Inc.1$21
Tris Pharma Inc1$20
Inspire Medical Systems, Inc.1$19
Biohaven Pharmaceutical Holding Company Ltd.1$19
Tactile Systems Technology Inc1$18
Ultragenyx Pharmaceutical Inc.1$18
GSK1$18
Novartis1$17
Avion Pharmaceuticals1$14
Impel Pharmaceuticals Inc.1$14

How this compares

$13,498 in reported general payments places this provider in the 90th percentile of 60 primary care providers in Utah.

See all primary care providers in Utah

Medicare billing

Part B allowed, 2024
$55,366
Medicare patients
145
Services billed
4,613

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other primary care in Riverton

See the full list for Utah

Where these figures come from

Is this you, or does something look wrong? →